Related references
Note: Only part of the references are listed.Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells
Dariush Haghmorad et al.
ACTA NEUROLOGICA BELGICA (2021)
New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect
Kosuke Shimizu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Molecular Interventions towards Multiple Sclerosis Treatment
Athanasios Metaxakis et al.
BRAIN SCIENCES (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
TGF-β in Mice Ameliorates Experimental Autoimmune Encephalomyelitis in Regulating NK Cell Activity
J. Xu et al.
CELL TRANSPLANTATION (2019)
Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis (vol 14, e0214738, 2019)
Milad Azami et al.
PLOS ONE (2019)
Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D3
Dariush Haghmorad et al.
NEUROLOGICAL RESEARCH (2019)
Neurodegeneration in multiple sclerosis and neuromyelitis optica
Izumi Kawachi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog
Sofia Fernanda Goncalves Zorzella-Pezavento et al.
FRONTIERS IN IMMUNOLOGY (2017)
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in inflammatory Demyelinating Diseases
Patrick Peschl et al.
FRONTIERS IN IMMUNOLOGY (2017)
TGF- regulation of encephalitogenic and regulatory T cells in multiple sclerosis
Priscilla W. Lee et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation
Fernanda V. Duraes et al.
JOURNAL OF AUTOIMMUNITY (2016)
Role of the Blood-Brain Barrier in Multiple Sclerosis
Genaro Gabriel Ortiz et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells
Dariush Haghmorad et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
Agata Walczak et al.
JAMA NEUROLOGY (2013)
Current and emerging therapies in multiple sclerosis: a systematic review
Wanda Castro-Borrero et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Inhibition of Reactive Astrocytosis in Established Experimental Autoimmune Encephalomyelitis Favors Infiltration by Myeloid Cells Over T Cells and Enhances Severity of Disease
Henrik Toft-Hansen et al.
GLIA (2011)
Oligodendrocytes: biology and pathology
Monika Bradl et al.
ACTA NEUROPATHOLOGICA (2010)
Characterization of Relapsing-Remitting and Chronic Forms of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice
Jennifer L. Berard et al.
GLIA (2010)
Therapeutic Effect of EDTA in Experimental Model of Multiple Sclerosis
G. Mosayebi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice
Jean Pierre S. Peron et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
Bassem Yamout et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
MOG35-55 i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways
Zhilong Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Loss of IFN-γ enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen
Joseph J. Sabatino et al.
JOURNAL OF IMMUNOLOGY (2008)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Oral tolerance: Therapeutic implications for autoimmune diseases
Ana M. C. Faria et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2006)
Natural recovery and protection from autoimmune encephalomyelitis:: Contribution of CD4+CD25+ regulatory cells within the central nervous system
MJ McGeachy et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis
MS Bynoe et al.
IMMUNITY (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Pathogenesis of multiple sclerosis: an update on immunology
B Hemmer et al.
CURRENT OPINION IN NEUROLOGY (2002)
Share Paper
